Signet Financial Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $721K | Sell |
11,892
-476
| -4% | -$27.7K | 0.08% | 183 |
|
|
2025
Q4 | $667K | Sell |
12,368
-742
| -6% | -$35.7K | 0.07% | 190 |
|
|
2025
Q3 | $591K | Buy |
13,110
+796
| +6% | +$37.2K | 0.07% | 192 |
|
|
2025
Q2 | $570K | Buy |
12,314
+51
| +0.4% | +$2.5K | 0.07% | 196 |
|
|
2025
Q1 | $748K | Sell |
12,263
-1,061
| -8% | -$61.8K | 0.1% | 174 |
|
|
2024
Q4 | $754K | Sell |
13,324
-3,633
| -21% | -$203K | 0.1% | 162 |
|
|
2024
Q3 | $877K | Sell |
16,957
-2,442
| -13% | -$115K | 0.11% | 150 |
|
|
2024
Q2 | $806K | Sell |
19,399
-329
| -2% | -$14.7K | 0.11% | 157 |
|
|
2024
Q1 | $1.07M | Buy |
+19,728
| New | +$1M | 0.15% | 147 |
|
|
2023
Q4 | – | Sell |
-3,502
| Closed | -$203K | – | 269 |
|
|
2023
Q3 | $203K | Sell |
3,502
-53
| -1% | -$3.25K | 0.03% | 253 |
|
|
2023
Q2 | $227K | Buy |
3,555
+4
| +0.1% | +$268 | 0.04% | 254 |
|
|
2023
Q1 | $246K | Sell |
3,551
-151
| -4% | -$10.7K | 0.04% | 243 |
|
|
2022
Q4 | $266K | Buy |
3,702
+87
| +2% | +$6.56K | 0.05% | 230 |
|
|
2022
Q3 | $257K | Sell |
3,615
-131
| -3% | -$9.5K | 0.05% | 220 |
|
|
2022
Q2 | $288K | Sell |
3,746
-102
| -3% | -$7.77K | 0.05% | 211 |
|
|
2022
Q1 | $281K | Buy |
3,848
+688
| +22% | +$46.2K | 0.05% | 216 |
|
|
2021
Q4 | $197K | Sell |
3,160
-351
| -10% | -$20.6K | 0.03% | 254 |
|
|
2021
Q3 | $208K | Buy |
+3,511
| New | +$231K | 0.04% | 242 |
|
|
2021
Q2 | – | Sell |
-3,276
| Closed | -$207K | – | 134 |
|
|
2021
Q1 | $207K | Buy |
+3,276
| New | +$204K | 0.04% | 227 |
|
|
2018
Q4 | – | Sell |
-3,730
| Closed | -$232K | – | 313 |
|
|
2018
Q3 | $232K | Sell |
3,730
-952
| -20% | -$56.5K | 0.04% | 211 |
|
|
2018
Q2 | $259K | Buy |
4,682
+2,564
| +121% | +$138K | 0.05% | 205 |
|
|
2018
Q1 | $134K | Sell |
2,118
-1,606
| -43% | -$103K | 0.02% | 248 |
|
|
2017
Q4 | $228K | Sell |
3,724
-498
| -12% | -$31.1K | 0.04% | 191 |
|
|
2017
Q3 | $269K | Sell |
4,222
-846
| -17% | -$49.4K | 0.05% | 168 |
|
|
2017
Q2 | $282K | Buy |
+5,068
| New | +$276K | 0.06% | 168 |
|
|
2017
Q1 | – | Sell |
-3,765
| Closed | -$220K | – | 195 |
|
|
2016
Q4 | $220K | Sell |
3,765
-497
| -12% | -$27.2K | 0.05% | 162 |
|
|
2016
Q3 | $230K | Sell |
4,262
-50
| -1% | -$3.21K | 0.05% | 149 |
|
|
2016
Q2 | $317K | Sell |
4,312
-2,121
| -33% | -$150K | 0.07% | 137 |
|
|
2016
Q1 | $411K | Buy |
6,433
+2,617
| +69% | +$165K | 0.09% | 127 |
|
|
2015
Q4 | $262K | Buy |
+3,816
| New | +$252K | 0.05% | 161 |
|
|
2015
Q3 | – | Sell |
-4,049
| Closed | -$269K | – | 188 |
|
|
2015
Q2 | $269K | Buy |
+4,049
| New | +$267K | 0.06% | 153 |
|
Other funds holding BMY
VCM
VPM
Signet Financial Management's BMY Position: Q1 2026 in Review
Signet Financial Management reduced its Bristol-Myers Squibb (BMY) stake by 3.8% in Q1 2026, selling an estimated $27.7K and leaving 11,892 shares worth $721K. The position accounts for 0.08% of the portfolio, ranked #183.
Signet Financial Management first reported a position in BMY in Q2 2015 and has held it in 31 quarters since. The position peaked at $1.07M in Q1 2024. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Signet Financial Management held 11,892 shares of Bristol-Myers Squibb worth $721K as of Q1 2026.
- Signet Financial Management sold 476 Bristol-Myers Squibb shares in Q1 2026, an estimated $27.7K.
- Bristol-Myers Squibb made up 0.08% of Signet Financial Management's portfolio in Q1 2026, its #183 holding.
- Signet Financial Management first reported a position in Bristol-Myers Squibb in Q2 2015 and has held it in 31 quarters since.
- Signet Financial Management's Bristol-Myers Squibb position peaked at $1.07M in Q1 2024.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Signet Financial Management's 13F filing for Q1 2026, filed 5 May 2026.